Alina Clinical Trials, LLC.

Dallas, Texas 75225-6301

4 studies enrolling now · 12 studies all time

What they study most

Asthma, Atopic Dermatitis, COVID-19, Chronic Rhinosinusitis With Nasal Polyps, Chronic Spontaneous Urticaria, Migraine, Moderate to Severe Chronic Obstructive Pulmonary Disease, SARS-CoV-2 Infection, Severe Asthma

Studies at this site

• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma — Recruiting now
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Enrolling by invitation
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
• A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) — Running, not enrolling
• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) — Completed
• A Study of S-892216 in Participants With COVID-19 — Completed
• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps — Completed
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed